Tang Capital Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Hold |
671,134
| – | – | 0.17% | 103 |
|
|
2025
Q1 | $2.03M | Hold |
671,134
| – | – | 0.11% | 117 |
|
|
2024
Q4 | $2.43M | Hold |
671,134
| – | – | 0.16% | 100 |
|
|
2024
Q3 | $1.18M | Hold |
671,134
| – | – | 0.08% | 105 |
|
|
2024
Q2 | $1.05M | Buy |
671,134
+200,000
| +42% | +$312K | 0.11% | 92 |
|
|
2024
Q1 | $919K | Hold |
471,134
| – | – | 0.1% | 89 |
|
|
2023
Q4 | $664K | Hold |
471,134
| – | – | 0.06% | 109 |
|
|
2023
Q3 | $744K | Buy |
471,134
+321,134
| +214% | +$507K | 0.11% | 89 |
|
|
2023
Q2 | $324K | Buy |
150,000
+26,570
| +22% | +$57.4K | 0.05% | 92 |
|
|
2023
Q1 | $259K | Hold |
123,430
| – | – | 0.04% | 93 |
|
|
2022
Q4 | $270K | Sell |
123,430
-990,023
| -89% | -$2.17M | 0.04% | 82 |
|
|
2022
Q3 | $3.34M | Hold |
1,113,453
| – | – | 0.41% | 55 |
|
|
2022
Q2 | $3.15M | Hold |
1,113,453
| – | – | 0.48% | 40 |
|
|
2022
Q1 | $5.96M | Hold |
1,113,453
| – | – | 1.19% | 25 |
|
|
2021
Q4 | $8.32M | Hold |
1,113,453
| – | – | 1.67% | 16 |
|
|
2021
Q3 | $10.1M | Buy |
+1,113,453
| New | +$10.1M | 2.1% | 12 |
|
|
2017
Q1 | – | Sell |
-19,959
| Closed | -$601K | – | 6 |
|
|
2016
Q4 | $601K | Hold |
19,959
| – | – | 0.32% | 7 |
|
|
2016
Q3 | $889K | Hold |
19,959
| – | – | 0.37% | 7 |
|
|
2016
Q2 | $777K | Buy |
19,959
+6,388
| +47% | +$249K | 0.35% | 11 |
|
|
2016
Q1 | $749K | Buy |
+13,571
| New | +$749K | 0.34% | 13 |
|